Marathon Asset Management, a global credit manager with more than $23 billion of assets under management, closed a senior-secured credit facility to finance H.I.G. Capital’s acquisition of SkinCure Oncology Intermediate.
SkinCure Oncology’s executive team, led by Kerwin Brandt, CEO, will continue to lead the company and remain significant shareholders.
“SkinCure Oncology has a tremendous track record for delivering outcomes for both its physician partners and patients,” Curtis Lueker, head of direct lending for Marathon Asset Management, said. “The company is an established leader in the industry, and we are excited to partner with H.I.G. and their strong management team to execute on their strategic vision and expansion to provide increased options and access to care for patients with NMSC.”
“The power of Marathon’s integrated investment platform, utilizing the expertise and combined capabilities of our dedicated Healthcare Finance and Direct Lending teams, enabled us to provide a reliable, thoughtful, and efficient financing solution for a best-in-class sponsor in H.I.G.,” Bruce Richards, chairman and CEO of Marathon Asset Management, said. “Marathon’s Private Credit platform is designed as a one-stop shop, offering corporate, asset-based, and capital solutions, including senior and junior financings ranging from $50 million to $250 million.”
